Athena M. Countouriotis
2017
In 2017, Athena M. Countouriotis earned a total compensation of $1.7M as Former Senior Vice President and Chief Medical Officer at Halozyme Therapeutics, a 10% decrease compared to previous year.
Compensation breakdown
| Option Awards | $550,000 |
|---|---|
| Salary | $236,493 |
| Stock Awards | $550,006 |
| Other | $323,773 |
| Total | $1,660,272 |
Countouriotis received $550K in stock awards, accounting for 33% of the total pay in 2017.
Countouriotis also received $550K in option awards, $236.5K in salary and $323.8K in other compensation.
Rankings
In 2017, Athena M. Countouriotis' compensation ranked 6,462nd out of 14,666 executives tracked by ExecPay. In other words, Countouriotis earned more than 55.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,462 out of 14,666 | 56th |
Division Manufacturing | 2,382 out of 5,770 | 59th |
Major group Chemicals And Allied Products | 760 out of 2,074 | 63rd |
Industry group Drugs | 586 out of 1,730 | 66th |
Industry Biological Products, Except Diagnostic Substances | 106 out of 316 | 67th |
Source: SEC filing on March 22, 2018.
Countouriotis' colleagues
We found four more compensation records of executives who worked with Athena M. Countouriotis at Halozyme Therapeutics in 2017.